In Reply

Affiliations

¹ iMAH Hematology Associates, New Hyde Park, New York.
² Division of Nephrology, University of Texas Southwestern School of Medicine, Dallas, Texas.

Comment

Han-Mou Tsai et al. Obstet Gynecol. 2016 Sep.

. 2016 Sep;128(3):657-658.

doi: 10.1097/AOG.0000000000001611.

¹ iMAH Hematology Associates, New Hyde Park, New York.
² Division of Nephrology, University of Texas Southwestern School of Medicine, Dallas, Texas.

No abstract available

Comment on

From Gestational Hypertension and Preeclampsia to Atypical Hemolytic Uremic Syndrome.
Tsai HM, Kuo E. Tsai HM, et al. Obstet Gynecol. 2016 May;127(5):907-910. doi: 10.1097/AOG.0000000000001340. Obstet Gynecol. 2016. PMID: 27054930
From Gestational Hypertension and Preeclampsia to Atypical Hemolytic Uremic Syndrome.
Burwick RM, Feinberg BB. Burwick RM, et al. Obstet Gynecol. 2016 Sep;128(3):657. doi: 10.1097/AOG.0000000000001610. Obstet Gynecol. 2016. PMID: 27548541 No abstract available.

1. Haeger M, Unander M, Bengtsson A. Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 1990;76:698–702.
1. Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien JK, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 2005;17:239–45.
1. Nurnberger J, Philipp T, Witzke O, Opazo SA, Vester U, Baba HA, et al. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med 2009;360:542–4.
1. Gruppo RA, Rother RP. Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med 2009;360:544–6.
1. Barilla-Labarca ML, Toder K, Furie R. Targeting the complement system in systemic lupus erythematosus and other diseases. Clin Immunol 2013;148:313–21.